← Eichor
Study identifier: NCT07249008 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

NSS Grocery Store Brazil

Condition: Control Group · Mexico-based NSS FOPL · Brazil-based NSS FOPL  ·  Sponsor: George Washington University

PhaseNA
Planned participants1068
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of this study is to assess the impact of non-sugar sweeteners (NSS) front-of-package labels (FOPL) on Brazilian parents' food and beverage selections for their children. The study includes three arms: 1. no NSS FOPL control group, 2. a group exposed to a NSS FOPL modeled after the Mexican warning label for NSS, and 3. a group exposed to a NSS FOPL using the magnifying glass symbol currently implemented in Brazil for nutrients of public health concern. Participants will be instructed to select products for their child, including one yogurt, three beverages (for breakfast, lunch, and dinner), one granola, and one cereal bar.

This description comes directly from the study's public registry record.

Talk to the study team

Allison C Sylvetsky, PhD  ·  +1 202-994-9412  ·  asylvets@email.gwu.edu

Mariana Fagundes Grilo, MHP  ·  marianafg@gwu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Milken Institute School of Public HealthWashington D.C., District of Columbia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07249008